Biofrontera AG (BFRA): Price and Financial Metrics
Biofrontera AG (BFRA)
Today's Latest Price: $8.23 USD
Updated Jan 20 6:55pm
Add BFRA to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 239 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
BFRA Stock Summary
- With a one year PEG ratio of 0.64, Biofrontera AG is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than only 6.04% of US stocks.
- Of note is the ratio of Biofrontera AG's sales and general administrative expense to its total operating expenses; 98.58% of US stocks have a lower such ratio.
- Revenue growth over the past 12 months for Biofrontera AG comes in at 130.84%, a number that bests 95.54% of the US stocks we're tracking.
- Stocks with similar financial metrics, market capitalization, and price volatility to Biofrontera AG are ANTE, UUU, TGEN, AFI, and TBLT.
- BFRA's SEC filings can be seen here. And to visit Biofrontera AG's official web site, go to www.biofrontera.com.
BFRA Stock Price Chart Interactive Chart >
BFRA Price/Volume Stats
| Current price | $8.23 | 52-week high | $55.00 |
| Prev. close | $8.21 | 52-week low | $5.27 |
| Day low | $8.05 | Volume | 35,500 |
| Day high | $8.35 | Avg. volume | 129,967 |
| 50-day MA | $7.28 | Dividend yield | N/A |
| 200-day MA | $8.29 | Market Cap | 196.48M |
Biofrontera AG (BFRA) Company Bio
Biofrontera AG, a biopharmaceutical company, primarily focuses on the discovery, development, and distribution of dermatological drugs and dermatologically tested cosmetics for the treatment and care of diseased skin. Biofrontera AG was founded in 1997 and is based in Leverkusen, Germany.
Loading social stream, please wait...